In glioma research, a bioinformatics analysis in the CGGA microarray and RNA sequencing databases showed that the levels of YTHDC2, YTHDF1, YTHDF2, and YTHDF3 were elevated in gliomas (Wang et al., 2021). The gene discussed is YTHDC2; the disease is central nervous system cancer.